
Nephrolithiasis affects approximately 12% of men and 7% of women during their lifetime and carries significant recurrence rates without metabolic evaluation and prevention. Calcium oxalate stones predominate; management includes dietary modification, pharmacological prophylaxis, and procedural intervention for obstructing or large stones. Emerging research targets oxalate metabolism with RNA interference and small molecule approaches.